SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Celsion Corporation Announces Unanimous Recommendation by Independent Data Monitoring Committee to Continue and Complete Phase III HEAT Study of ThermoDox(R) in Primary Liver Cancer as Planned